These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 233635)

  • 21. Effects of catecholamine-beta-adrenoceptor-cAMP system on severe patients with heart failure.
    Peng Y; Shan J; Qi X; Xue H; Rong C; Yao D; Guo Z; Zheng S
    Chin Med J (Engl); 2003 Oct; 116(10):1459-63. PubMed ID: 14570600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased activity of low-Km cyclic adenosine 3':5'-monophosphate phosphodiesterase in plasma membranes of Morris hepatoma 5123tc (h).
    Hickie RA; Walker CM; Datta A
    Cancer Res; 1975 Mar; 35(3):601-5. PubMed ID: 163686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiologic features of swine dysentery: cyclic nucleotide-independent production of diarrhea.
    Schmall LM; Argenzio RA; Whipp SC
    Am J Vet Res; 1983 Jul; 44(7):1309-16. PubMed ID: 6309041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.
    DeRubertis FR; Chayoth R; Field JB
    J Clin Invest; 1976 Mar; 57(3):641-9. PubMed ID: 175089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Variations of plasmatic cyclic nucleotides in the asthmatic patient (cyclic adenosine monophosphate and cyclic guanosine monophosphate) (author's transl)].
    Clauzel AM; Calvayrac P; Michel FB
    Poumon Coeur; 1980; 36(5):295-302. PubMed ID: 6256723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the metabolism of exogenous cyclic AMP by perfused rat heart and incubated prepubertal rat ovary.
    Rosberg S; Selstam G; Isaksson O
    Acta Physiol Scand; 1975 Aug; 94(4):522-35. PubMed ID: 170793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
    Wang TY; Hussey CV; Sasse EA; Fobian JE
    Ann Clin Lab Sci; 1978; 8(5):403-12. PubMed ID: 213009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cAMP radioimmunoassay without interference from calcium or EDTA.
    Chiang CS; Kowalski AJ
    Clin Chem; 1982 Jan; 28(1):150-2. PubMed ID: 6276046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
    Kaplan EL; Fang VS; Sugimoto J; Fredland A
    Surgery; 1982 Nov; 92(5):822-6. PubMed ID: 6291182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine 3',5'-monophosphate response to parathyroid hormone: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ; Spiegel AM; Sharp ME; Brown EM; Gardner DG; Downs RW; Attie MF; Stock JL
    J Clin Endocrinol Metab; 1980 Mar; 50(3):546-8. PubMed ID: 6244324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experiences with a protein-binding technic for the determination of adenosine 3:5 monophosphate (cAMP) in plasma].
    Kuhn H; Mäurer W; Breithardt G; Kübler W
    Verh Dtsch Ges Inn Med; 1974; 80():1707-10. PubMed ID: 4375899
    [No Abstract]   [Full Text] [Related]  

  • 33. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
    J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine 3',5'-monophosphate in plasma, urine, and native and isoproterenol-stimulated leukocytes of dogs.
    Kristensen S; Larsen LM; Larsen PO; Bendixen PH
    Am J Vet Res; 1977 Nov; 38(11):1869-71. PubMed ID: 201201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of cyclic adenosine 3',5'-monophosphate (cAMP) in urine for the diagnosis of primary hyperparathyroidism].
    Schmidt-Gayk H; Röher HD; Seyberth HW
    Chirurg; 1973 Jun; 44(6):272-4. PubMed ID: 4353321
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of [3H]AMP binding to rat adipose plasma membranes and its substrate specificity.
    Yegutkin GG
    Membr Cell Biol; 1997; 11(4):441-7. PubMed ID: 9553932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary cyclic 3',5'-adenosine monophosphate (cAMP) in diabetic subjects with and without symptomatic hypoglycemia and in normal subjects with insulin-induced hypoglycemia.
    Lilienfeld-Toal H; Willms B
    Horm Metab Res; 1976 Jul; 8(4):279-81. PubMed ID: 182632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of cyclic AMP in hyperparathyroidism.
    Wålinder O; Ljunghall S; Wibell L
    Scand J Urol Nephrol; 1978; 12(1):67-71. PubMed ID: 204993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma cyclic adenosine 3',5'-monophosphate (cAMP) levels in hyperthyroid patients.
    Velardo A; Baronti D; Pasargiklian E
    Exp Clin Endocrinol; 1983 Aug; 82(2):238-41. PubMed ID: 6313403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.